Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B I Sikic

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2000
New approaches in cancer treatmentB I Sikic
Oncology (Williston Park, N.Y.)|June 17, 1999
Modulation of multidrug resistance: a paradigm for translational clinical researchB I Sikic
Journal of the National Cancer Institute|June 5, 1991
Anticancer drug discoveryB I Sikic
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Modulation of multidrug resistance: at the thresholdB I Sikic
Seminars in Hematology|December 31, 1997
Pharmacologic approaches to reversing multidrug resistanceB I Sikic
Current Opinion in Oncology|December 1, 1989
Antitumor antibioticsB I Sikic
Frontiers of Radiation Therapy and Oncology|January 1, 1992
Combined chemotherapy and radiotherapy for advanced-stage carcinomas of the cervixB I Sikic
Cancer Surveys|January 1, 1986
Biochemical and cellular determinants of bleomycin cytotoxicityB I Sikic
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell deathC Dumontet, B I Sikic
Hematology/Oncology Clinics of North America|April 1, 1995
Clinical studies with modulators of multidrug resistanceG A Fisher, B I Sikic
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2000
New approaches in cancer treatmentB I Sikic
Oncology (Williston Park, N.Y.)|June 17, 1999
Modulation of multidrug resistance: a paradigm for translational clinical researchB I Sikic
Journal of the National Cancer Institute|June 5, 1991
Anticancer drug discoveryB I Sikic
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Modulation of multidrug resistance: at the thresholdB I Sikic
Seminars in Hematology|December 31, 1997
Pharmacologic approaches to reversing multidrug resistanceB I Sikic
Current Opinion in Oncology|December 1, 1989
Antitumor antibioticsB I Sikic
Frontiers of Radiation Therapy and Oncology|January 1, 1992
Combined chemotherapy and radiotherapy for advanced-stage carcinomas of the cervixB I Sikic
Cancer Surveys|January 1, 1986
Biochemical and cellular determinants of bleomycin cytotoxicityB I Sikic
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell deathC Dumontet, B I Sikic
Hematology/Oncology Clinics of North America|April 1, 1995
Clinical studies with modulators of multidrug resistanceG A Fisher, B I Sikic
Pageof 13